Action Myconic Capital - MEDI

Outils de qualité professionnelle, pour des investisseurs individuels.

Premium

Dernier

1,85

Prix Achat

1,81

Prix Vente

1,85

Volume échangé

0,00 Fourchette du Jour 0,00

1,85 Plage de 52 semaines 1,85

Clôture Veille

1,85

Ouverture

Dernière Transaction

Dernière heure de transaction

Volume moyen (3 m)

Volume financier

VWAP

MedImmune, Inc. Announces Make-Whole Fundamental Change Relating to its 1.375% Convertible Senior Notes Due 2011 and 1.625% Conv

GAITHERSBURG, Md., June 18 /PRNewswire-FirstCall/ -- MedImmune, Inc. today announced that, in connection with the closing of the acquisition of...

MedImmune Wins Stevie(R) Award at 5th Annual American Business Awards(SM)

Biotechnology Company Honored for Internal Launch of Productivity Tracking System GAITHERSBURG, Md., June 12 /PRNewswire-FirstCall/...

MedImmune Named One of Maryland's Fastest Growing Technology Companies in Deloitte Technology Fast 50 Program

- 10th Consecutive Year for MedImmune on the Fast 50 List - GAITHERSBURG, Md., Sept. 29 /PRNewswire-FirstCall/ -- MedImmune, Inc. has been named...

MedImmune Named One Of Maryland's Fastest Growing Technology Companies In Deloitte Technology Fast 50 Program

GAITHERSBURG, Md., Oct. 12 /PRNewswire-FirstCall/ -- MedImmune, Inc. has been named to Deloitte's Maryland Technology Fast 50 program for the...

Standard & Poor's Announces Semi-Annual Reconstitution of Standard & Poor's/Barra Growth and Value Indices

Standard & Poor's Announces Semi-Annual Reconstitution of Standard & Poor's/Barra Growth and Value Indices NEW YORK, Dec. 10 /PRNewswire/...

Data Show Ethyol(R) Reduces Radiation Therapy-Induced Dry Mouth in Head and Neck Cancer Patients For 24 Months

Data Show Ethyol(R) Reduces Radiation Therapy-Induced Dry Mouth in Head and Neck Cancer Patients For 24 Months NEW ORLEANS, June 6...

Période	Variation	Variation %	Ouver.	Haut	Bas	Moyenne Vol. Quot.	VWAP
1	0	0	1.85	1.85	1.85	0	0	CS
4	0	0	1.85	1.85	1.85	0	0	CS
12	0	0	1.85	1.85	1.85	0	0	CS
26	0	0	1.85	1.85	1.85	0	0	CS
52	0	0	1.85	1.85	1.85	0	0	CS
156	0	0	1.85	1.85	1.85	0	0	CS
260	-4.65	-71.5384615385	6.5	6.5	0.26	2302	1.14091857	CS

MEDI - Frequently Asked Questions (FAQ)

What is the current Myconic Capital share price?

The current share price of Myconic Capital is $ 1,85

What is the 1 year trading range for Myconic Capital share price?

Myconic Capital has traded in the range of $ 1,85 to $ 1,85 during the past year

Volume
% Gagnants
% Perdants

Symbole	Prix	Vol.
WBGDWaraba Gold Limited	$ 0,015 (200,00%)	582k
CSSCascada Silver Corp	$ 0,01 (100,00%)	100k
LTHMChampion Electric Metals Inc	$ 0,01 (100,00%)	11k
ETIEnviroMetal Technologies Inc	$ 0,01 (100,00%)	15k
OBRNOberon Uranium Corp	$ 0,01 (100,00%)	261,9k
PUMPStock Trend Capital Inc	$ 0,005 (-50,00%)	344,03k
BLRBlackhawk Growth Corp	$ 0,005 (-50,00%)	4,12k
FUTRGold n Futures Mineral Corp	$ 0,005 (-50,00%)	4k
FFNT4Front Ventures Corp	$ 0,005 (-50,00%)	390k
CRVCCross River Ventures Corp	$ 0,005 (-50,00%)	620k
SNAStar Navigation Systems Group Ltd	$ 0,005 (0,00%)	4,83M
HVWHi View Resources Inc	$ 0,03 (20,00%)	4,09M
WHIPCredissential Inc	$ 0,035 (75,00%)	4,03M
TWOH.XTwo Hands Corporation	$ 0,005 (0,00%)	3,79M
AIMLAl ML Innovations Inc	$ 0,095 (18,75%)	2,32M

Forums

Afficher les forums

Aucune Discussion Trouvée

Ajouter une Discussion

Donnée du Marché

Actualité

Outils

Donnée du Marché

Discover

Hot Features

Follow Feed

Flux des Options

Moniteur

Myconic Capital Corp (MEDI)

Outils de qualité professionnelle, pour des investisseurs individuels.

Statistiques et détails clés

MEDI Dernières nouvelles

MedImmune, Inc. Announces Make-Whole Fundamental Change Relating to its 1.375% Convertible Senior Notes Due 2011 and 1.625% Conv

MedImmune Wins Stevie(R) Award at 5th Annual American Business Awards(SM)

MedImmune Named One of Maryland's Fastest Growing Technology Companies in Deloitte Technology Fast 50 Program

MedImmune Named One Of Maryland's Fastest Growing Technology Companies In Deloitte Technology Fast 50 Program

Standard & Poor's Announces Semi-Annual Reconstitution of Standard & Poor's/Barra Growth and Value Indices

Data Show Ethyol(R) Reduces Radiation Therapy-Induced Dry Mouth in Head and Neck Cancer Patients For 24 Months

MEDI - Frequently Asked Questions (FAQ)

Moteurs

Forums

Dernières Valeurs Consultées

Société

Entreprise

Popular

Obtenir l'application

Donnée du Marché

Actualité

Outils

Donnée du Marché

Discover

Hot Features

Follow Feed

Flux des Options

Moniteur

Myconic Capital Corp (MEDI) Cours

Myconic Capital Corp (MEDI)

Outils de qualité professionnelle, pour des investisseurs individuels.

Statistiques et détails clés

MEDI Dernières nouvelles

MedImmune, Inc. Announces Make-Whole Fundamental Change Relating to its 1.375% Convertible Senior Notes Due 2011 and 1.625% Conv

MedImmune Wins Stevie(R) Award at 5th Annual American Business Awards(SM)

MedImmune Named One of Maryland's Fastest Growing Technology Companies in Deloitte Technology Fast 50 Program

MedImmune Named One Of Maryland's Fastest Growing Technology Companies In Deloitte Technology Fast 50 Program

Standard & Poor's Announces Semi-Annual Reconstitution of Standard & Poor's/Barra Growth and Value Indices

Data Show Ethyol(R) Reduces Radiation Therapy-Induced Dry Mouth in Head and Neck Cancer Patients For 24 Months

MEDI - Frequently Asked Questions (FAQ)

Moteurs

Forums

Dernières Valeurs Consultées

Société

Entreprise

Popular

Obtenir l'application

Supprimer les publicités